Bacterial Toxin Research Citations

April 10, 2024

Nature

Du, G;Healy, LB;David, L;Walker, C;El-Baba, TJ;Lutomski, CA;Goh, B;Gu, B;Pi, X;Devant, P;Fontana, P;Dong, Y;Ma, X;Miao, R;Balasubramanian, A;Puthenveetil, R;Banerjee, A;Luo, HR;Kagan, JC;Oh, SF;Robinson, CV;Lieberman, J;Wu, H;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

in Columns (ThermoFisher, 88274) according to the 1159 manufacturers protocol. 2 ?g/mL endotoxin-removed active and inactive flatox proteins were 1160 mixed with 2 ?g/mL Anthrax Protective Antigen (List Biological Laboratories, 171E) and then were 1161 added to iBMDMs. After 6 hours, cells were treated or n

April 8, 2024

Chemistry (Weinheim An Der Bergstrasse, Germany)

Verpalen, ECJM;Brouwer, AJ;Wolfert, MA;Boons, GJ;

Product: LPS from Escherichia coli O55:B5

5?:?B5 LPS (Lot # 20318?A4) was obtained from List Biologicals. All data presented in this study were generated with the same batch of E. coli 055?:?B5 LPS. The synthetic lipid A derivatives were reconstituted as 2?mg/mL in 90?% THF/10?% water. Stock solutions in small aliquots were stored at ?80?°C. Cytokine induction and ELISAs. MM6?cells were harvested on the day of the exposure assay and diluted to 1.11 ×106?cells/mL and plated as 200??L/well

April 5, 2024

Brain Structure & Function

Dereli, AS;Oh, AYS;McMullan, S;Kumar, NN;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

glass capillary micropipette of diameter 20-40 ?m at 6.2 mm deep to lambda (1%; List Biological, Campbell, CA) (Fig. 1). The pipette was left in place for 5 min before withdrawal. At the conclusion of injections, the incision was closed with silk sutures, isoflurane was discontinued, and once a

April 5, 2024

International Journal Of Molecular Sciences

Shamsher, E;Khan, RS;Davis, BM;Dine, K;Luong, V;Cordeiro, MF;Shindler, KS;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

A total of 200 ng of pertussis toxin (List Biological, Campbell, CA, USA) was injected intraperitoneally in control and immunized mice at immunization and 2 days post

April 5, 2024

Cell Communication And Signaling : Ccs

Chung, YK;Chan, HY;Lee, TY;Wong, YH;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

btained from Thermofisher Scientific (Waltham, MA, USA). Polyethylenimine (PEI) (Linear, MW 25,000) was purchased from Polysciences, Inc. (Warrington, PA, USA). Pertussis toxin (PTX) was ordered from List Biological Laboratories (Campbell, CA, USA). Forskolin and quinpirole hydrochloride were purchased from Tocris Bioscience (Bristol, UK). The [3H]adenine was purchased from American Radiolabeled C ... btained from Thermofisher Scientific (Waltham, MA, USA). Polyethylenimine (PEI) (Linear, MW 25,000) was purchased from Polysciences, Inc. (Warrington, PA, USA). Pertussis toxin (PTX) was ordered from List Biological Laboratories (Campbell, CA, USA). Forskolin and quinpirole hydrochloride were purchased from Tocris Bioscience (Bristol, UK). The [3H]adenine was purchased from American Radiolabeled C

April 4, 2024

Frontiers In Microbiology

Wan, S;You, P;Shi, Q;Hu, H;Zhang, L;Chen, L;Wu, Z;Lin, S;Song, X;Luo, Y;Wang, Y;Ju, F;Jin, D;Chen, Y;

Product: Toxin B from Clostridium difficile

TcdB polyclonal antibodies (List Biological Laboratories Campbell, CA, United States; Pure TcdB toxin (List Biological Laboratories) was used as the positive control, and

April 2, 2024

Molecular Psychiatry

Gaitonde, S;Avet, C;Revenga, M;Blondel-Tepaz, É;Shahraki, A;Pastor, A;Talagayev, V;Robledo, P;Kolb, P;Selent, J;González?Maeso, J;Bouvier, M;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

concentration at the respective pathways) and incubated for an additional 5?min after which a second BRET read (antagonist mode) was conducted. To assess the role of G?i/o proteins in 5-HT-mediated responses, cells were pretreated with pertussis toxin (PTX;100?ng/mL, 18?h; List Biological Laboratories) before agonist stimulation

April 2, 2024

Cellular And Molecular Life Sciences : Cmls

Marrocco, R;Bernard, I;Joulia, E;Barascud, R;Dejean, AS;Lesourne, R;Saoudi, A;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Mice were injected intravenously with 200 ng of pertussis toxin (List Biological Laboratories, Campbell, CA.) at days 0 and 2 post-immunization. Clinical scores were

April 1, 2024

Research Square

Silva-Santos, B;Cunha, C;Romero, P;Inácio, D;Pais, A;Pelicano, C;Costa, M;Mensurado, S;Gonçalves-Sousa, N;Papotto, P;Neves, D;Sobral, D;Enguita, F;Gomes, A;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

M. tuberculosis in IFA) (Difco Laboratories). On the day of immunization and 2 days after, mice received 200 ng of pertussis toxin (PTx) (List Biological Laboratories) in 100 µl PBS i.v. Mice were weighed daily and scored for EAE clinical signs. In brief, the score system ranged from 0 to 5, with 0.5 increments, being score 0 attributed to an

April 1, 2024

Eneuro

Dusing, MR;LaSarge, CL;Drake, AW;Westerkamp, GC;McCoy, C;Hetzer, SM;Kraus, KL;Pedapati, EV;Danzer, SC;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

e 1, Experiment 1), followed by a week of baseline 24/7 video-EEG monitoring. Beginning in the fourth week after virus injections, mice were treated with diphtheria toxin or saline. Diphtheria toxin (List Biological Laboratories, #150) was prepared in sterile normal saline at 0.1?mg/ml and stored frozen in aliquots at ?80°C. Diphtheria toxin was diluted to a concentration of 5?ng/µl the da ... e 1, Experiment 1), followed by a week of baseline 24/7 video-EEG monitoring. Beginning in the fourth week after virus injections, mice were treated with diphtheria toxin or saline. Diphtheria toxin (List Biological Laboratories, #150) was prepared in sterile normal saline at 0.1?mg/ml and stored frozen in aliquots at ?80°C. Diphtheria toxin was diluted to a concentration of 5?ng/µl the da

Bacterial Toxin Research Citations

ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D

Structure-Based Design and Synthesis of Lipid A Derivatives to Modulate Cytokine Responses

Galaninergic and hypercapnia-activated neuronal projections to the ventral respiratory column

Intranasal Resveratrol Nanoparticles Enhance Neuroprotection in a Model of Multiple Sclerosis

Inhibition of adenylyl cyclase by GTPase-deficient G?i is mechanistically different from that mediated by receptor-activated G?i

Gut microbiome changes in mouse, Mongolian gerbil, and hamster models following Clostridioides difficile challenge

Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor

Positive regulation of Vav1 by Themis controls CD4 T cell pathogenicity in a mouse model of central nervous system inflammation

MicroRNAs -122 and -1247 restrain the pathogenicity of effector CD4+ T cells in autoimmune inflammation

Transient Seizure Clusters and Epileptiform Activity Following Widespread Bilateral Hippocampal Interneuron Ablation